Banerjee Antara, Bhattacharya Parna, Dagur Pradeep K, Karmakar Subir, Ismail Nevien, Joshi Amritanshu B, Akue Adovi D, KuKuruga Mark, McCoy John Philip, Dey Ranadhir, Nakhasi Hira L
Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993.
Department of Zoology, Bangabasi College, Kolkata, 700016 West Bengal, India.
J Immunol. 2018 Jan 1;200(1):163-176. doi: 10.4049/jimmunol.1700674. Epub 2017 Nov 29.
No vaccine exists against visceral leishmaniasis. To develop effective vaccines, we have previously reported protective role of live attenuated centrin gene-deleted ( ) parasites through induction of Th1 type immune response in mice, hamsters, and dogs. In this study, we specifically explored the role of Th17 cells in -induced host protection in mice. Our results showed that compared with wild-type infection, parasites induce significantly higher expression of Th17 differentiation cytokines in splenic dendritic cells. There was also induction of IL-17 and its promoting cytokines in total splenocytes and in both CD4 and CD8 T cells following immunization with Upon challenge with wild-type parasites, IL-17 and its differentiating cytokines were significantly higher in -immunized mice compared with nonimmunized mice that resulted in parasite control. Alongside IL-17 induction, we observed induction of IFN-γ-producing Th1 cells as reported earlier. However, Th17 cells are generated before Th1 cells. Neutralization of either IL-17 or IFN-γ abrogated -induced host protection further confirming the essential role of Th17 along with Th1 cytokines in host protection. Treatment with recombinant IL-23, which is required for stabilization and maintenance of IL-17, heightened Th17, and Tc17 responses in immunized mice splenocytes. In contrast, Th17 response was absent in immunized IL-23R mice that failed to induce protection upon virulent challenge suggesting that IL-23 plays an essential role in IL-17-mediated protection by parasites. This study unveiled the role of IL-23-dependent IL-17 induction in parasite-induced immunity and subsequent protection against visceral leishmaniasis.
目前尚无针对内脏利什曼病的疫苗。为开发有效的疫苗,我们之前报道过减毒活中心体基因缺失( )寄生虫通过在小鼠、仓鼠和犬体内诱导Th1型免疫反应发挥的保护作用。在本研究中,我们专门探讨了Th17细胞在 诱导的小鼠宿主保护中的作用。我们的结果表明,与野生型 感染相比, 寄生虫在脾树突状细胞中诱导Th17分化细胞因子的表达显著更高。在用 免疫后,总脾细胞以及CD4和CD8 T细胞中也诱导产生了IL-17及其促进细胞因子。在用野生型寄生虫攻击后,与未免疫的小鼠相比, 免疫的小鼠中IL-17及其分化细胞因子显著更高,从而实现了对寄生虫的控制。与之前报道的一样,在诱导IL-17的同时,我们还观察到了产生IFN-γ的Th1细胞的诱导。然而,Th17细胞在Th1细胞之前产生。中和IL-17或IFN-γ均可消除 诱导的宿主保护作用,进一步证实了Th17以及Th1细胞因子在宿主保护中的重要作用。用重组IL-23处理可增强免疫小鼠脾细胞中的Th17和Tc17反应,IL-23是稳定和维持IL-17所必需的。相比之下,免疫的IL-23R小鼠中不存在Th17反应,在受到强毒 攻击时未能诱导出保护作用,这表明IL-23在 寄生虫介导的IL-17保护作用中起重要作用。本研究揭示了IL-23依赖性IL-17诱导在 寄生虫诱导的免疫及随后针对内脏利什曼病的保护中的作用。